Research led by Duke Health in collaboration with the University of Minnesota has found that small RNA molecules known as piRNAs can accurately predict whether older adults are likely to survive at least two more years.

Researchers at Duke and UNC-Chapel Hill have uncovered a set of bacterial survival genes activated only inside TB’s hard‑to‑study granulomas, revealing new clues to how the pathogen endures our immune defenses.

On February 25, 2026, North Carolinians took a shot at making history. Duke School of Medicine led a statewide effort to break the world record for the most people trained in hands-only CPR in a single day. While falling short of the 30,000 person goal, almost 20 thousand participants learned CPR – a benchmark day for trainings in the United States.

In this conversation, Dr. Sulman reflects on what drew him to Duke, outlines his goals for strengthening Radiation Oncology’s clinical, research, and educational missions, and shares how innovation—from precision therapies to new technologies—is shaping the field.

They may lead different employee resource groups (ERGs), but Magaly Guerrero and Antonio Jones share a similar vision for what belonging at Duke can look like. It’s a vision that will guide them as the newly named leaders of Duke University School of Medicine’s two ERGs.

Duke Eye Center discovery may explain how vision can stay surprisingly strong even when the eye’s structure is disrupted.

A new study offers the first comparative, state level evidence that raising the minimum age of firearm access for young adults with juvenile justice histories may reduce gun-involved violent crime. Researchers from Duke University, Yale University, the University of Virginia, and the University of Delaware collaborated on the study, which was published in the Journal of Interpersonal Violence.

Duke University Sc

In the first episode of the new “Conversations in Cancer” video series from the Duke Cancer Institute, Duke Health medical oncologist Diane Reidy-Lagunes, MD, and DCI cancer vaccine researcher Zachary Hartman, PhD, discuss cancer vaccines: what they are, how they work, and what’s on the horizon.